ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Scopus Q2SCImago #10,568Gold OA

Neuropsychopharmacology Reports

Identifier (ISSN):2574-173X(Print)
•
Publisher:Wiley-Blackwell
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
1.9↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Neuropsychopharmacology Reports

WoS Q4
12342.52023220241.520251.92026
Annual Impact Factor Metric
Current (2026):1.9
Scopus SJR & RankScopus Q2
0.561
#10,568

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
27

27 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
69articles/year
100% Gold OA•93.51% Original Research

Aims & Scope

Neuropsychopharmacology Reports (ISSN: 2574-173X) is a peer-reviewed international scholarly journal in the field of Psychology, published by Wiley-Blackwell in Australia. The periodical holds a Journal Impact Factor (JIF) of 1.90, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.561 (Q2), an H-index of 27.

Topics Covered (Recognized by AI)
MedicinePsychologyBiologyPsychiatryInternal MedicineNeuroscienceComputer ScienceEndocrinologyChemistryBiochemistryGeneticsPathologyPharmacologyProgramming LanguagesClinical PsychologyCognitive ScienceMathematicsReceptors & Pharmacology
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

NEUROSCIENCES

Q4
Rank266/330
IndexESCI
JCRESCI2026

PHARMACOLOGY & PHARMACY

Q3
Rank253/356
IndexESCI
JCRESCI2026

PSYCHIATRY

Q3
Rank187/293
IndexESCI
JCIESCI2026

NEUROSCIENCES

Q4
Rank281/330
IndexESCI
JCIESCI2026

PHARMACOLOGY & PHARMACY

Q3
Rank252/356
IndexESCI
JCIESCI2026

PSYCHIATRY

Q3
Rank216/293
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

10 year
2026Latest
IF1.9
Articles / Year69
Total Citations11
2025
IF1.5
Articles / Year105
Total Citations182
2024
IF2
Articles / Year112
Total Citations432
2023
IF2.5
Articles / Year103
Total Citations568
2022
IF—
Articles / Year88
Total Citations605

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,568Scopus Q2SCImago Profile
Scopus Coverage:2018-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and PharmaceuticsPsychology
Scopus Citation Rank (SJR)Q2
0.561

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.05

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,040 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations507
3-Year Documents260
Citable Documents260

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate30.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Clinical PsychologyQ2
PharmacologyQ3
Pharmacology (medical)Q3
Psychiatry and Mental HealthQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区NEUROSCIENCES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Neuropsychopharmacology Reports (ISSN: 2574-173X) is a peer-reviewed international scholarly journal in the field of Psychology, published by Wiley-Blackwell in Australia. The periodical holds a Journal Impact Factor (JIF) of 1.90, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.561 (Q2), an H-index of 27.

The journal enforces rigorous peer evaluation with an annual output of approximately 69 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,040 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Wiley-Blackwell
Publication Language
English
Frequency
Periodic
Indexing & Databases
ScopusDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 2ebc56c0-8305-41db-900d-0997ca06c340
Database Updated: 2026-09-28